DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

31.95 -0.51 (-1.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AEGR $31.95 -1.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.11
Previous Close $32.46
Daily Range $31.65 - $32.64
52-Week Range $26.25 - $101.00
Market Cap $944.0M
P/E Ratio -18.55
Dividend (Yield) $0.00 (0.0%)
Volume 1,289,556
Average Daily Volume 1,096,556
Current FY EPS -$0.93

Sector

Healthcare

Industry

Drugs

Aegerion Pharmaceuticals, Inc. (AEGR) Description

Aegerion Pharmaceuticals, Inc. Website: http://www.aegerion.com/

News & Commentary

Why Investors Continue to Flee Aegerion Stock

In theory Aegerion could still reach this peaks sales figure (quite easily) given that there are many more reimbursable HoFH patients out there, but it appears that Amgen’s (AMGN) hugely successful PCSK9 inhibitor evolocumab will dethrone Juxtapid before that happens.

Aegerion Pharmaceuticals (AEGR) Highlighted As Today's Perilous Reversal Stock

Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program

Aegerion Resolves FDA's Warning on Juxtapid, Lifts Overhang - Analyst Blog

Today's Perilous Reversal Stock: Aegerion Pharmaceuticals (AEGR)

Sector Update: Health Care Stocks Holding On To Small Gains; Aegerion Pharma Rising After Resolving

Sector Update: Health Care Stocks Holding On To Small Gains; Aegerion Pharma Rising After Resolving Juxtapid Issues with Regulators

Sector Update: Health Care

Aegerion Pharmaceuticals Announces Resolution Of Warning Letter for JUXTAPID (lomitapide) Capsules

Insider Trading Alert - GBX, AEGR And ABG Traded By Insiders

Aegerion Pharmaceuticals Is Still Significantly Overvalued

Why Aegerion Pharmaceuticals (AEGR) Stock Is Down Today

See More AEGR News...

AEGR's Top Competitors

AEGR $31.95 (-1.57%)
Current stock: AEGR
JNJ $104.72 (0.13%)
Current stock: JNJ
NVS $94.18 (0.45%)
Current stock: NVS
RHHBY $36.96 (0.71%)
Current stock: RHHBY